All Search Results
News Releases
Jul 26, 2024, 16:00 ET Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine (CVM) has granted the Company a sponsor fee waiver and assigned
More news about: Innocan Pharma Corporation
Jul 26, 2024, 16:00 ET Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine (CVM) has granted the Company a sponsor fee waiver and assigned
More news about: Innocan Pharma Corporation
Jul 26, 2024, 10:30 ET Cell Isolation/Separation Market worth $8.4 billion by 2029 driven by Growing Emphasis on Technological Advancements | MarketsandMarkets™.
Pharmaceutical & Biotechnology Companies Lead The cell isolation market is segmented by end user into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, and other users. In 2023, pharmaceutical and biotechnology companies dominated
More news about: MarketsandMarkets
Jul 26, 2024, 10:16 ET Specialty Enzymes Market to Surpass USD 10.4 Billion by 2034, Growing at a 6.4% CAGR: Digital Technologies and Automation Drive Efficiency and Cost Reduction | TMR
specialty enzymes market is expanding due to the rising demand for effective biocatalysts in pharmaceuticals and diagnostics, which drives innovation. Biotechnology and genetic engineering advancements have enabled the development of more efficient and specific enzymes, broadening their application scope.
More news about: Transparency Market Research
Jul 26, 2024, 10:01 ET Pharmerging Market Set to Hit USD 7.1 Billion by 2034, Driven by Surge in Demand for Cost-Effective Innovative Drugs and Comprehensive Insurance Policies | Report by TMR
pharmacies more accessible in emerging markets.Innovations in biotechnology and personalized medicine are propelling pharmaceutical research and development. This results in novel treatments and therapies being introduced. Biotechnology advancements are propelling the creation of customized medications
More news about: Transparency Market Research
Organizations
Resources
Case Studies
PhRMA Increases Blog Readership & Reaches Broader Audiences with Content Syndication
PhRMA, the Pharmaceutical Research and Manufacturers of America, represents leading innovative biopharmaceutical research and biotechnology companies. PhRMA is devoted to advancing public policies in the U.S. and around the world to support innovative medical research, help patients